Community pharmacists' and assistant pharmacists' perspectives on non-prescription analgesics in Erbil: a cross-sectional study

Shanaz Kadhim Magdid
Department of Pharmacy, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region, Iraq
Sherzad Abdulahad Shabu
Department of Community Medicine, College of Medicine, Hawler Medical University, Erbil, Kurdistan Region, Iraq
Share:

Abstract

Background and objectives: Community pharmacists play a crucial role in providing counselling on self-medication using non-prescription analgesics (NPAs); ensuring pharmacy staff have adequate expertise is critical for safe and effective patient care. This study aimed to assess the knowledge of pharmacists and assistant pharmacists in Erbil City regarding NPAs.

Methods: A cross-sectional survey was conducted among 400 community pharmacy staff in Erbil. A structured questionnaire assessed demographic characteristics and knowledge of NPAs, including their uses, side effects, interactions, and appropriate populations. Chi-square tests were used to explore associations between knowledge level and participant characteristics.

Results: The majority of participants (90.3%, n = 361) demonstrated sufficient knowledge of NPAs, while a smaller percentage (9.8%, n = 39) had poor knowledge. Significant gaps were found in pediatric dosage, NSAID interactions, and use in high-risk populations. Gender (p = 0.006) and academic degree (p < 0.001) were significantly associated with knowledge level. Female participants had significantly higher knowledge than males (93.8% vs. 85.0% sufficient knowledge, respectively), and bachelor's degree holders also had significantly higher knowledge than diploma and postgraduate participants (93.8%, 86.8%, and 57.1% sufficient knowledge, respectively).

Conclusion: Community pharmacy professionals in Erbil demonstrated sufficient knowledge regarding NPAs overall, but gaps in safety-related knowledge remain that could put patient care at risk. To close these gaps, those in non-clinical roles and postgraduates should receive specialized training and participate in ongoing education.

Metrics

Metrics Loading ...

References

  1. Feizerfan A, Sheh G. Transition from acute to chronic pain. Contin Educ Anaesth Crit Care Pain. 2015;15(2):98-102. https://doi.org/10.1093/bjaceaccp/mku044
  2. Zimmer Z, Fraser K, Grol-Prokopczyk H, Zajacova A. A global study of pain prevalence across 52 countries: examining the role of country-level contextual factors. Pain. 2022;163(9):1740-50. https://doi.org/10.1097/j.pain.0000000000002557
  3. Blyth FM, Schneider CH. Global burden of pain and global pain policy — creating a purposeful body of evidence. Pain. 2018;159(Suppl 1):S43-8. https://doi.org/10.1097/j.pain.0000000000001311
  4. Moore RA, Wiffen PJ, Derry S, Maguire T, Roy YM, Tyrrell L. Non-prescription (OTC) oral analgesics for acute pain — an overview of Cochrane reviews. Cochrane Database Syst Rev. 2015;(11):CD010794. https://doi.org/10.1002/14651858.CD010794.pub2
  5. Musich S, Wang SS, Slindee LB, Ruiz J, Yeh CS. Concurrent use of opioids with other central nervous system-active medications among older adults. Popul Health Manag. 2020;23(4):286-96. https://doi.org/10.1089/pop.2019.0128
  6. Hagen M, Alchin J. Nonprescription drugs recommended in guidelines for common pain conditions. Pain Manag. 2020;10(2):117-29. https://doi.org/10.2217/pmt-2019-0057
  7. Mohammed SS, Azar BH, Baram A. Chronic thoracic pain in cardiothoracic surgery via thoracotomy and sternotomy: risk factors and outcomes. Adv Med J. 2026;11(2):219-28. https://doi.org/10.56056/amj.2026.478
  8. Chidiac AS, Buckley NA, Noghrehchi F, Cairns R. Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease. Expert Opin Drug Metab Toxicol. 2023;19(5):297-317. https://doi.org/10.1080/17425255.2023.2223959
  9. Wróblewski T, Kobryń K, Kozieł S, Ołdakowska-Jedynak U, Pinkas J, Danielewicz R, et al. Acetaminophen (paracetamol) induced acute liver failure — a social problem in an era of increasing tendency to self-treatment. Ann Agric Environ Med. 2015;22(4):762-7. https://doi.org/10.5604/12321966.1185790
  10. Kulkarni GB, Mathew T, Mailankody P. Medication overuse headache. Neurol India. 2021;69(Suppl 1):S76-82. https://doi.org/10.4103/0028-3886.315981
  11. Zafeiri A, Mitchell RT, Hay DC, Fowler PA. Over-the-counter analgesics during pregnancy: a comprehensive review of global prevalence and offspring safety. Hum Reprod Update. 2021;27(1):67-95. https://doi.org/10.1093/humupd/dmaa042
  12. Ziesenitz VC, Zutter A, Erb TO, van den Anker JN. Efficacy and safety of ibuprofen in infants aged between 3 and 6 months. Pediatr Drugs. 2017;19:277-90. https://doi.org/10.1007/s40272-017-0235-3
  13. Targhi M, Benamer W, Elghnimi T, Hussiny M, Mashmmor AA. Community pharmacies behind the scenes. AlQalam J Med Appl Sci. 2023;2023:694-700. https://doi.org/10.5281/zenodo.10138334
  14. Rutter P. Role of community pharmacists in patients' self-care and self-medication. Integr Pharm Res Pract. 2015;4:57-65. https://doi.org/10.2147/IPRP.S70403
  15. Aziz AA, Abdulla SA. Knowledge of pharmacy staff regarding over-the-counter medications in Erbil City. Erbil J Nurs Midwifery. 2019;2(2):144-54. https://doi.org/10.15218/ejnm.2019.18
  16. Abdulrahman IA, Saleh AM. Assessment of pharmacists' knowledge, attitude, and practice toward over-the-counter medications in Erbil city: a cross-sectional study. Zanco J Med Sci. 2026;30(1):121-34. https://doi.org/10.15218/zjms.2026.009
  17. Alzahrani F, Alahmadi YM, Thagfan SSA, Alolayan S, Elbadawy HM. Migraine management in community pharmacies: knowledge, attitude and practice patterns of pharmacists in Saudi Arabia. Pharmacy (Basel). 2023;11(5):155. https://doi.org/10.3390/pharmacy11050155
  18. Jairoun AA, Al-Hemyari SS, Shahwan M, Jairoun M, Kurdi A, Godman B. Assessing knowledge, attitude and practice of community pharmacists on the pain management and implications in UAE children. Pharm Pract (Granada). 2022;20(2):2664. https://doi.org/10.18549/PharmPract.2022.2.2664
  19. Alorfi NM. Prescribing patterns and pharmacological knowledge of analgesics among community pharmacists in Jeddah, Saudi Arabia. Bull Pharm Sci Assiut Univ. 2023;46(1):647-57. https://doi.org/10.21608/bfsa.2023.301293
  20. Alorfi NM, Ashour AM, Algarni AS, Alsolami FA, Alansari AM, Tobaiqy M. Assessment of the community pharmacists' knowledge and attitudes toward pain and pain management in Saudi Arabia. Int J Gen Med. 2022;15:8527-37. https://doi.org/10.2147/IJGM.S387066
  21. Malebari AM, Khayyat AN, Mahdali RA, Alamoudi JS, Alsayed BY, Alrasheed SA. Evaluation of the community pharmacists' performance in the screening of non-steroidal anti-inflammatory drugs risks in Saudi Arabia. Saudi Med J. 2020;41(8):849-55. https://doi.org/10.15537/smj.2020.8.25221
  22. Mujtaba SH, Gazerani P. Exploring the role of community pharmacists in pain management: enablers and challenges. Pharmacy (Basel). 2024;12(4):111. https://doi.org/10.3390/pharmacy12040111
How to Cite
Kadhim Magdid , S., & Abdulahad Shabu, S. . (2026). Community pharmacists’ and assistant pharmacists’ perspectives on non-prescription analgesics in Erbil: a cross-sectional study . Zanco Journal of Medical Sciences (ZJMS), 601–614. https://doi.org/10.15218/zjms.2026.041

Send mail to Author


Send Cancel